These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 34993483)
1. Quantitative cerebrospinal fluid circulating tumor cells are a potential biomarker of response for proton craniospinal irradiation for leptomeningeal metastasis. Wijetunga NA; Boire A; Young RJ; Yamada Y; Wolden S; Yu H; Kris M; Seidman A; Betof-Warner A; Diaz M; Reiner A; Malani R; Pentsova E; Yang JT Neurooncol Adv; 2021; 3(1):vdab181. PubMed ID: 34993483 [TBL] [Abstract][Full Text] [Related]
2. Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal Metastases. Wijetunga NA; Goglia AG; Weinhold N; Berger MF; Cislo M; Higginson DS; Chabot K; Osman AM; Schaff L; Pentsova E; Miller AM; Powell SN; Boire A; Yang JT Clin Cancer Res; 2023 Feb; 29(4):775-783. PubMed ID: 36449664 [TBL] [Abstract][Full Text] [Related]
3. Randomized Phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for Patients With Solid Tumor Leptomeningeal Metastasis. Yang JT; Wijetunga NA; Pentsova E; Wolden S; Young RJ; Correa D; Zhang Z; Zheng J; Steckler A; Bucwinska W; Bernstein A; Betof Warner A; Yu H; Kris MG; Seidman AD; Wilcox JA; Malani R; Lin A; DeAngelis LM; Lee NY; Powell SN; Boire A J Clin Oncol; 2022 Nov; 40(33):3858-3867. PubMed ID: 35802849 [TBL] [Abstract][Full Text] [Related]
4. Quantitative assessment of circulating tumor cells in cerebrospinal fluid as a clinical tool to predict survival in leptomeningeal metastases. Diaz M; Singh P; Kotchetkov IS; Skakodub A; Meng A; Tamer C; Young RJ; Reiner AS; Panageas KS; Ramanathan LV; Pentsova E J Neurooncol; 2022 Mar; 157(1):81-90. PubMed ID: 35113288 [TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer. Malani R; Fleisher M; Kumthekar P; Lin X; Omuro A; Groves MD; Lin NU; Melisko M; Lassman AB; Jeyapalan S; Seidman A; Skakodub A; Boire A; DeAngelis LM; Rosenblum M; Raizer J; Pentsova E J Neurooncol; 2020 Jul; 148(3):599-606. PubMed ID: 32506369 [TBL] [Abstract][Full Text] [Related]
6. Clinical trial of proton craniospinal irradiation for leptomeningeal metastases. Yang TJ; Wijetunga NA; Yamada J; Wolden S; Mehallow M; Goldman DA; Zhang Z; Young RJ; Kris MG; Yu HA; Seidman AD; Gavrilovic IT; Lin A; Santomasso B; Grommes C; Piotrowski AF; Schaff L; Stone JB; DeAngelis LM; Boire A; Pentsova E Neuro Oncol; 2021 Jan; 23(1):134-143. PubMed ID: 32592583 [TBL] [Abstract][Full Text] [Related]
7. Proton Craniospinal Irradiation with Immunotherapy in Two Patients with Leptomeningeal Disease from Melanoma. Sener U; Webb M; Breen WG; Neth BJ; Laack NN; Routman D; Brown PD; Mahajan A; Frechette K; Dudek AZ; Markovic SN; Block MS; McWilliams RR; Dimou A; Kottschade LA; Montane HN; Kizilbash SH; Campian JL J Immunother Precis Oncol; 2024 Feb; 7(1):1-6. PubMed ID: 38327758 [TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors. Lin X; Fleisher M; Rosenblum M; Lin O; Boire A; Briggs S; Bensman Y; Hurtado B; Shagabayeva L; DeAngelis LM; Panageas KS; Omuro A; Pentsova EI Neuro Oncol; 2017 Sep; 19(9):1248-1254. PubMed ID: 28821205 [TBL] [Abstract][Full Text] [Related]
9. Detection of Circulating Tumor Cells in Cerebrospinal Fluid of Patients with Suspected Breast Cancer Leptomeningeal Metastases: A Prospective Study. Darlix A; Cayrefourcq L; Pouderoux S; Menjot de Champfleur N; Bievelez A; Jacot W; Leaha C; Thezenas S; Alix-Panabières C Clin Chem; 2022 Oct; 68(10):1311-1322. PubMed ID: 35953885 [TBL] [Abstract][Full Text] [Related]
10. A retrospective, quantitative assessment of disease burden in patients with leptomeningeal metastases from non-small-cell lung cancer. Nevel KS; DiStefano N; Lin X; Skakodub A; Ogilvie SQ; Reiner AS; Pentsova E; Boire A Neuro Oncol; 2020 May; 22(5):675-683. PubMed ID: 32352148 [TBL] [Abstract][Full Text] [Related]
11. Integration of rare cell capture technology into cytologic evaluation of cerebrospinal fluid specimens from patients with solid tumors and suspected leptomeningeal metastasis. Torre M; Lee EQ; Chukwueke UN; Nayak L; Cibas ES; Lowe AC J Am Soc Cytopathol; 2020; 9(1):45-54. PubMed ID: 31606331 [TBL] [Abstract][Full Text] [Related]
12. Molecular characteristics and prognostic factors of leptomeningeal metastasis in non-small cell lung cancer. Liu X; Li G; Zhang H; Chang Q; Fang M; Lu C; Tian P; Mei F Clin Neurol Neurosurg; 2023 Feb; 225():107572. PubMed ID: 36610238 [TBL] [Abstract][Full Text] [Related]
13. The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer. Davies CR; Guo T; Burke E; Stankiewicz E; Xu L; Mao X; Scandura G; Rajan P; Tipples K; Alifrangis C; Wimalasingham AG; Galazi M; Crusz S; Powles T; Grey A; Oliver T; Kudahetti S; Shaw G; Berney D; Shamash J; Lu YJ Front Oncol; 2022; 12():1060864. PubMed ID: 36727071 [TBL] [Abstract][Full Text] [Related]
14. Circulating tumor cell characterization of lung cancer brain metastases in the cerebrospinal fluid through single-cell transcriptome analysis. Ruan H; Zhou Y; Shen J; Zhai Y; Xu Y; Pi L; Huang R; Chen K; Li X; Ma W; Wu Z; Deng X; Wang X; Zhang C; Guan M Clin Transl Med; 2020 Dec; 10(8):e246. PubMed ID: 33377642 [TBL] [Abstract][Full Text] [Related]
15. [Value of serum human epithelial growth factor receptor 2 extracellular domain and circulating tumor cells in evaluating therapeutic response in advanced gastric cancer]. Li Y; Peng Z; Zhang X; Gong J; Shen L Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Nov; 20(11):1293-1299. PubMed ID: 29178102 [TBL] [Abstract][Full Text] [Related]
16. Prospective study revealed prognostic significance of responses in leptomeningeal metastasis and clinical value of cerebrospinal fluid-based liquid biopsy. Xu Y; Hu M; Zhang M; Zhong W; Yin X; Sun Y; Chen M; Zhao J; Si X; Wang H; Zhang X; Zhang L; Li J; Guan H; Yang Z; Wang M Lung Cancer; 2018 Nov; 125():142-149. PubMed ID: 30429013 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of syndecan-1, MUC-1, and putative stem cell markers in breast cancer leptomeningeal metastasis: a cerebrospinal fluid flow cytometry study. Cordone I; Masi S; Summa V; Carosi M; Vidiri A; Fabi A; Pasquale A; Conti L; Rosito I; Carapella CM; Villani V; Pace A Breast Cancer Res; 2017 Apr; 19(1):46. PubMed ID: 28399903 [TBL] [Abstract][Full Text] [Related]
18. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer. Mu Z; Wang C; Ye Z; Austin L; Civan J; Hyslop T; Palazzo JP; Jaslow R; Li B; Myers RE; Jiang J; Xing J; Yang H; Cristofanilli M Breast Cancer Res Treat; 2015 Dec; 154(3):563-71. PubMed ID: 26573830 [TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid circulating tumour DNA genotyping and survival analysis in lung adenocarcinoma with leptomeningeal metastases. Bai K; Chen X; Qi X; Zhang Y; Zou Y; Li J; Yu L; Li Y; Jiang J; Yang Y; Liu Y; Feng S; Bu H J Neurooncol; 2023 Oct; 165(1):149-160. PubMed ID: 37897649 [TBL] [Abstract][Full Text] [Related]
20. Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients. Wallwiener M; Riethdorf S; Hartkopf AD; Modugno C; Nees J; Madhavan D; Sprick MR; Schott S; Domschke C; Baccelli I; Schönfisch B; Burwinkel B; Marmé F; Heil J; Sohn C; Pantel K; Trumpp A; Schneeweiss A BMC Cancer; 2014 Jul; 14():512. PubMed ID: 25015676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]